Jeffrey Schwartz - Mar 6, 2025 Form 3 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Role
Director, 10%+ Owner
Signature
/s/ Jeffrey Schwartz
Stock symbol
KMTS
Transactions as of
Mar 6, 2025
Transactions value $
$0
Form type
3
Date filed
3/6/2025, 08:42 PM
Previous filing
May 28, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KMTS Common Shares 27M Mar 6, 2025 See footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 7,109,944 common shares of the Issuer held directly by Bain Charger Holdings, L.P. ("Bain Charger') and 19,909,281 common shares of the Issuer held directly by West Affum Holdings, L.P. ("West Affum").
F2 The common shares of the Issuer held by West Affum are held for the benefit of the holders of West Affum common units, including Bain Charger, until the time such common shares are distributed to the holders of West Affum common units in accordance with the partnership agreement of West Affum. Bain Charger is the sole shareholder of West Affum GP Ltd., which is the general partner of West Affum.
F3 Mr. Schwartz is a Partner of Bain Capital Life Sciences Investors, LLC, which is the ultimate general partner of Bain Capital Life Sciences Fund, LP. As a result, Mr. Schwartz may be deemed to share voting and dispositive power with respect to the securities held by Bain Charger and West Affum. Mr. Schwartz disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.